First VIV in Europe! Great outcome., page-17

now hear me out - i come in peace here, but I've always said that historically these types of announcements were very common in company communications, which is/was a good thing - however, for the average retail investor, they lost that punch long ago as historically these medically impactful announcements/progress never really resulted in any solid SP action - in fact, the opposite, SP continues to stagnate/even drop in the face of such positive announcements - for the medical industry, yes, they no doubt get the progress from that lens (practitioners and hopefully large competitors lurking in the shadows), but, on the ASX, its is treated with ho hum - history has done this. So, what will move it on the ASX? outside of a significant partnership it will be the road to commercialisation - i.e. these announcements need a so what to help the average retail investor - i.e. this announcement, so what? How does this help get the company to revenue, how does the company closer to self funding without brutal cap raises, how does it help the commercialisation path? These announcements and their significance need to be overlayed on the business strategy to help us non medical background retail investors put it all into perspective - does this announcement mean today is a better day to invest than yesterday, or tomorrow?